Log in

NYSE:USPH - U.S. Physical Therapy Stock Price, Forecast & News

$117.14
-0.42 (-0.36 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$115.05
Now: $117.14
$117.59
50-Day Range
$113.22
MA: $123.63
$147.27
52-Week Range
$98.69
Now: $117.14
$148.48
Volume90,433 shs
Average Volume110,700 shs
Market Capitalization$1.50 billion
P/E Ratio44.20
Dividend Yield1.03%
Beta1.04
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. Read More…

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.91 million
Cash Flow$3.43 per share
Book Value$17.10 per share

Profitability

Net Income$34.87 million

Miscellaneous

Employees4,600
Market Cap$1.50 billion
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.


U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Thursday, November 7th. Investors of record on Monday, November 18th will be given a dividend of $0.30 per share on Friday, December 13th. This represents a $1.20 annualized dividend and a dividend yield of 1.02%. The ex-dividend date is Friday, November 15th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, November, 7th. The company reported $0.71 EPS for the quarter, meeting the consensus estimate of $0.71. The firm earned $117.30 million during the quarter, compared to analyst estimates of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. U.S. Physical Therapy's revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.64 EPS. View U.S. Physical Therapy's Earnings History.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for U.S. Physical Therapy.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.94.

What price target have analysts set for USPH?

2 brokers have issued 12 month price objectives for U.S. Physical Therapy's stock. Their forecasts range from $106.61 to $130.00. On average, they expect U.S. Physical Therapy's stock price to reach $118.31 in the next twelve months. This suggests a possible upside of 1.0% from the stock's current price. View Analyst Price Targets for U.S. Physical Therapy.

What is the consensus analysts' recommendation for U.S. Physical Therapy?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for U.S. Physical Therapy.

Has U.S. Physical Therapy been receiving favorable news coverage?

Media headlines about USPH stock have been trending positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. U.S. Physical Therapy earned a coverage optimism score of 2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for U.S. Physical Therapy.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a drop in short interest during the month of November. As of November 15th, there was short interest totalling 1,150,000 shares, a drop of 5.7% from the October 31st total of 1,220,000 shares. Based on an average daily trading volume, of 87,900 shares, the short-interest ratio is currently 13.1 days. Currently, 9.2% of the company's stock are short sold. View U.S. Physical Therapy's Current Options Chain.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Allergan (AGN), UnitedHealth Group (UNH), Cisco Systems (CSCO), PepsiCo (PEP), Starbucks (SBUX), Lowe's Companies (LOW), Pfizer (PFE), Scotts Miracle-Gro (SMG), Union Pacific (UNP) and Amgen (AMGN).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (3.08%), Riverbridge Partners LLC (2.98%), Copeland Capital Management LLC (1.39%), Russell Investments Group Ltd. (0.95%), Boston Trust Walden Corp (0.92%) and Scout Investments Inc. (0.76%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Hancock Whitney Corp, grace capital, Alberta Investment Management Corp, Scout Investments Inc., Riverbridge Partners LLC, Systematic Financial Management LP and State of Tennessee Treasury Department. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Calamos Advisors LLC, SG Americas Securities LLC, First Trust Advisors LP, Voloridge Investment Management LLC, Bridge City Capital LLC, Rhumbline Advisers and State of Alaska Department of Revenue. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $117.14.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.50 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,600 workers across the globe.View Additional Information About U.S. Physical Therapy.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is http://www.usph.com/.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  200 (Vote Outperform)
Underperform Votes:  293 (Vote Underperform)
Total Votes:  493
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel